Article info

Download PDFPDF

Intravenous meloxicam for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects

Authors

  1. Correspondence to Randall J Mack, Recro Pharma, Inc, Malvern, PA 19355, USA; rmack{at}recropharma.com
View Full Text

Citation

Viscusi ER, Gan TJ, Bergese S, et al
Intravenous meloxicam for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects

Publication history

  • Received November 27, 2018
  • Accepted December 6, 2018
  • First published February 7, 2019.
Online issue publication 
February 18, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.